Anna M. Corsale

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experience.

Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experience.

Journal: Haematologica

Published: March 12, 2026

Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions.

Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions.

Journal: International journal of molecular sciences

Published: February 27, 2026

CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms.

CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms.

Journal: Oncology reviews

Published: February 10, 2026

Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study.

Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study.

Journal: International journal of molecular sciences

Published: November 12, 2025

Identification of CD320, SLC44A1 and TNFRSF13B as potential novel therapeutic targets for CAR T-cell therapy in multiple myeloma.

Identification of CD320, SLC44A1 and TNFRSF13B as potential novel therapeutic targets for CAR T-cell therapy in multiple myeloma.

Journal: Frontiers in medicine

Published: November 04, 2025

Inflammatory Biomarkers for Thrombotic Risk Assessment in Multiple Myeloma Patients on IMiD/aCD38-Based Regimens: Insights from a Prospective Observational Study.

Inflammatory Biomarkers for Thrombotic Risk Assessment in Multiple Myeloma Patients on IMiD/aCD38-Based Regimens: Insights from a Prospective Observational Study.

Journal: Biomolecules

Published: August 31, 2025

γδ T Cells in Glioblastoma Multiforme: Novel Roles and Therapeutic Opportunities.

γδ T Cells in Glioblastoma Multiforme: Novel Roles and Therapeutic Opportunities.

Journal: Cancers

Published: June 26, 2025

Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response.

Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response.

Journal: Blood neoplasia

Published: April 01, 2025

γδ T-Cell Immunophenotype for the Study of Human Aging.

γδ T-Cell Immunophenotype for the Study of Human Aging.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 30, 2024

BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia.

BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia.

Journal: Biomarker research

Published: September 19, 2024

In vivo Effects of Disease-modifying Therapies on Immunological Subsets in Patients with Relapsing-Remitting Multiple Sclerosis.

In vivo Effects of Disease-modifying Therapies on Immunological Subsets in Patients with Relapsing-Remitting Multiple Sclerosis.

Journal: Current neuropharmacology

Published: September 15, 2024

Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients.

Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients.

Journal: Experimental hematology & oncology

Published: June 02, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026